Back

OncoCyte Quote, Financials, Valuation and Earnings

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here

Sell

OCX
OncoCyte

Last Price:

2.76

Seasonality Move:

-19.6%

7 Day Trial

ALL ACCESS PASS

$ 7

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

OncoCyte Price Quote

$2.76

+0.19 (+7.39%)

(Updated: May 2, 2024 at 6:55 PM ET)

OncoCyte Key Stats

Sell

OncoCyte (OCX) is a Sell

Day range:

$2.50 - $2.57

52-week range:

$2.08 - $5.88

Dividend yield:

P/E ratio:

0.00

P/S ratio:

13.07

P/B ratio:

1.67%

Volume:

4.6K

Avg. volume:

108.9K

1-year change:

-53.26%

Market cap:

$34.3M

Revenue:

$1.5M

EPS:

$-3.55

How Much Does OncoCyte Make?

How Much Are OncoCyte's Sales Annually?
OCX Revenues are $1.5M
How Much Profit Does OncoCyte's Make A Year?
OCX net income is -$27.8M

Is OncoCyte Growing As A Company?

What Is OncoCyte's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15%
What Is OncoCyte's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

OncoCyte Stock Price Performance

Did OncoCyte Stock Go Up Last Month?
OncoCyte share price went down by -13.76% last month
Did OCX's Share Price Rise Over The Last Year?
OCX share price fell by -53.26% over the past 1 year

What Is OncoCyte 52-Week High & Low?

What Is OncoCyte’s 52-Week High Share Price?
OncoCyte has traded as high as $5.88 over the past 52 weeks
What Is OncoCyte’s 52-Week Low Share Price?
OncoCyte has traded as low as $2.08 over the past 52 weeks

OncoCyte Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy OncoCyte?

How Much Debt Does OncoCyte Have?
Total long term debt quarterly is $0
How Much Cash Does OncoCyte Have?
Cash and short term investments quarterly total is $9.4M
What Is OncoCyte’s Book Value Per Share?
Book value per share is 2.48

Is OncoCyte Cash Flow Positive?

What Is OCX Cash Flow From Operations?
Cash flow from operations (TTM) is -$23.3M
What Is OncoCyte’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.2M
What Is OncoCyte’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$932K

OncoCyte Return On Invested Capital

Is Management Doing A Good Job?
OCX return on invested capital is -79.9%
What Is OncoCyte Return On Assets?
ROA measures how assets are converting to revenues and is -32.54%
What Is OCX Return On Equity?
ROE is a measure of profitability and is -79.9%

OncoCyte Earnings Date & Stock Price

What Is OncoCyte's Stock Price Today?
A single share of OCX can be purchased today for 2.57
What Is OncoCyte’s Stock Symbol?
OncoCyte trades on the nasdaq under the ticker symbol: OCX
When Is OncoCyte’s Next Earnings Date?
The next quarterly earnings date for OncoCyte is scheduled on May 10, 2024
When Is OCX's next ex-dividend date?
OncoCyte's next ex-dividend date is May 2, 2024
How To Buy OncoCyte Stock?
You can buy OncoCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

OncoCyte Competitors

Who Are OncoCyte's Competitors?
Below is a list of companies who compete with OncoCyte or are related in some way:
- Applied DNA Sciences Inc (APDN)
- Fonar Corp (FONR)
- ProPhase Labs Inc (PRPH)
- Veracyte Inc (VCYT)
- XWELL Inc (XWEL)

OncoCyte Dividend Yield